Weight-Loss drug trial for pancreatic cancer halted early
Symptom relief
Terminated
This study tested a drug called anamorelin to see if it could help prevent weight loss and improve appetite in people with advanced pancreatic cancer who were starting chemotherapy. The trial planned to include about 100 participants but was stopped early after only 4 people enro…
Phase: PHASE2 • Sponsor: Lahey Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC